163 related articles for article (PubMed ID: 9714135)
1. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty.
Alaigh P; Hoffman CJ; Korlipara G; Neuroth A; Dervan JP; Lawson WE; Hultin MB
Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1281-6. PubMed ID: 9714135
[TBL] [Abstract][Full Text] [Related]
2. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
[TBL] [Abstract][Full Text] [Related]
3. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
[TBL] [Abstract][Full Text] [Related]
4. High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease.
Miyata M; Biro S; Arima S; Hamasaki S; Kaieda H; Nakao S; Kawataki M; Nomoto K; Tanaka H
Am Heart J; 1996 Aug; 132(2 Pt 1):269-73. PubMed ID: 8701886
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty.
Hearn JA; Donohue BC; Ba'albaki H; Douglas JS; King SB; Lembo NJ; Roubin GS; Sgoutas DS
Am J Cardiol; 1992 Mar; 69(8):736-9. PubMed ID: 1532112
[TBL] [Abstract][Full Text] [Related]
6. Absence of a prothrombotic state in restenotic patients?
Brack MJ; More RS; Pringle S; Gershlick AH
Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
[TBL] [Abstract][Full Text] [Related]
7. The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty.
Tenda K; Saikawa T; Maeda T; Sato Y; Niwa H; Inoue T; Yonemochi H; Maruyama T; Shimoyama N; Aragaki S
Jpn Circ J; 1993 Aug; 57(8):789-95. PubMed ID: 8355396
[TBL] [Abstract][Full Text] [Related]
8. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
Sakata K; Miura F; Sugino H; Shinobe M; Shirotani M; Yoshida H; Mori N; Hoshino T; Takada A
Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
[TBL] [Abstract][Full Text] [Related]
9. Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty.
Sirikci O; Aytekin V; Demiroglu IC; Demiroglu C; Marcovina SM
Int J Clin Lab Res; 2000; 30(2):93-9. PubMed ID: 11043503
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty.
Chiarugi L; Prisco D; Antonucci E; Capanni M; Fedi S; Liotta AA; Margheri M; Simonetti I; Gensini GF; Abbate R
Atherosclerosis; 2001 Jan; 154(1):129-35. PubMed ID: 11137091
[TBL] [Abstract][Full Text] [Related]
11. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group.
Daida H; Lee YJ; Yokoi H; Kanoh T; Ishiwata S; Kato K; Nishikawa H; Takatsu F; Kato H; Kutsumi Y
Am J Cardiol; 1994 Jun; 73(15):1037-40. PubMed ID: 8198026
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty.
Desmarais RL; Sarembock IJ; Ayers CR; Vernon SM; Powers ER; Gimple LW
Circulation; 1995 Mar; 91(5):1403-9. PubMed ID: 7867180
[TBL] [Abstract][Full Text] [Related]
13. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
14. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for restenosis after percutaneous transluminal coronary angioplasty: role of lipoprotein (a).
Yamamoto H; Imazu M; Yamabe T; Ueda H; Hattori Y; Yamakido M
Am Heart J; 1995 Dec; 130(6):1168-73. PubMed ID: 7484765
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease.
Cooke T; Sheahan R; Foley D; Reilly M; D'Arcy G; Jauch W; Gibney M; Gearty G; Crean P; Walsh M
Circulation; 1994 Apr; 89(4):1593-8. PubMed ID: 8149526
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA): LDL-apheresis angioplasty restenosis trial (L-ART).
Yamaguchi H; Lee YJ; Daida H; Yokoi H; Miyano H; Kanoh T; Ishiwata S; Kato K; Nishikawa H; Takatsu F
Chem Phys Lipids; 1994 Jan; 67-68():399-403. PubMed ID: 8187240
[TBL] [Abstract][Full Text] [Related]
19. The influence of plasma lipoprotein (a) on angiographic restenosis and coronary events in patients undergoing planned coronary balloon angioplasty. Ancillary analysis of the Fluvastatin Angioplasty Restenosis (FLARE) trial.
Lloyd GW; Jackson G; Foley DP; Boersma E; Shepherd J; Serruys PW
Atherosclerosis; 2001 Oct; 158(2):445-54. PubMed ID: 11583725
[TBL] [Abstract][Full Text] [Related]
20. Impaired fibrinolysis determines the outcome of percutaneus transluminal coronary angioplasty (PTCA).
Fornitz GG; Nielsen P; Amtorp O; Kassis E; Abildgård U; Sloth C; Winther K; Ørskov H; Dalsgård J; Husted S
Eur J Clin Invest; 2001 Jul; 31(7):586-92. PubMed ID: 11454013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
